The Parliament has declared on March 14 that National Pharmaceutical Price Authority (NPPA) has received nearly Rs 672.28 cr as fine till date from the pharma companies for overcharging medicines. The list of overcharged drugs includes commonly used medicines such as Gelusil, Soframycin and Ring-Guard.
The price regulator in the pharmaceutical industry, NPPA, had discovered that the leading Pharma companies are overcharging customers for abundantly prevalent drugs in the market.
NPPA had alleged that the listed 634 drugs are being sold at prices higher than their ceiling price fixed by the Drug Price Control Order (DPCO). The list included Pharma giants like Sun Pharmaceuticals, Lupin Pharma, Cipla, Cadila Healthcare and many more.